- Home
- SLGL vs NOTE Comparison
SLGL vs NOTE Comparison
Compare SLGL & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- NOTE
- Stock Information
- Founded
- SLGL 1997
- NOTE 2013
- Country
- SLGL Israel
- NOTE United States
- Employees
- SLGL N/A
- NOTE N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- NOTE EDP Services
- Sector
- SLGL Health Care
- NOTE Technology
- Exchange
- SLGL Nasdaq
- NOTE Nasdaq
- Market Cap
- SLGL 69.1M
- NOTE 63.9M
- IPO Year
- SLGL 2018
- NOTE N/A
- Fundamental
- Price
- SLGL $37.00
- NOTE $3.99
- Analyst Decision
- SLGL Strong Buy
- NOTE Strong Buy
- Analyst Count
- SLGL 1
- NOTE 4
- Target Price
- SLGL $50.00
- NOTE $29.25
- AVG Volume (30 Days)
- SLGL 16.8K
- NOTE 257.5K
- Earning Date
- SLGL 11-14-2025
- NOTE 11-12-2025
- Dividend Yield
- SLGL N/A
- NOTE N/A
- EPS Growth
- SLGL N/A
- NOTE N/A
- EPS
- SLGL N/A
- NOTE N/A
- Revenue
- SLGL $23,931,000.00
- NOTE $109,683,000.00
- Revenue This Year
- SLGL N/A
- NOTE N/A
- Revenue Next Year
- SLGL $31.17
- NOTE $4.61
- P/E Ratio
- SLGL N/A
- NOTE N/A
- Revenue Growth
- SLGL 264.86
- NOTE N/A
- 52 Week Low
- SLGL $4.01
- NOTE $3.80
- 52 Week High
- SLGL $52.26
- NOTE $24.36
- Technical
- Relative Strength Index (RSI)
- SLGL 53.73
- NOTE 41.32
- Support Level
- SLGL $38.01
- NOTE $3.98
- Resistance Level
- SLGL $42.00
- NOTE $4.54
- Average True Range (ATR)
- SLGL 3.42
- NOTE 0.27
- MACD
- SLGL -0.95
- NOTE -0.13
- Stochastic Oscillator
- SLGL 30.02
- NOTE 0.91
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.